Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

429 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
[Hereditary ovarian cancer: summary of 5 years of experience].
Menkiszak J, Jakubowska A, Gronwald J, Rzepka-Górska I, Lubiński J. Menkiszak J, et al. Among authors: jakubowska a. Ginekol Pol. 1998 May;69(5):283-7. Ginekol Pol. 1998. PMID: 9695328 Polish.
Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer.
Górski B, Byrski T, Huzarski T, Jakubowska A, Menkiszak J, Gronwald J, Pluzańska A, Bebenek M, Fischer-Maliszewska L, Grzybowska E, Narod SA, Lubiński J. Górski B, et al. Among authors: jakubowska a. Am J Hum Genet. 2000 Jun;66(6):1963-8. doi: 10.1086/302922. Epub 2000 Apr 28. Am J Hum Genet. 2000. PMID: 10788334 Free PMC article.
A total of 26 families had both breast and ovarian cancers, 4 families had ovarian cancers only, and 36 families had breast cancers only. ...The single family with a BRCA2 mutation had the breast-ovarian cancer syndrome. Seven distinct mutations were identified; fiv
A total of 26 families had both breast and ovarian cancers, 4 families had ovarian cancers only, and 36 families had breast cancers o
Ovarian cancer of endometrioid type as part of the MSH6gene mutation phenotype.
Suchy J, Kurzawski G, Jakubowska A, Lubiński J. Suchy J, et al. Among authors: jakubowska a. J Hum Genet. 2002;47(10):529-31. doi: 10.1007/s100380200079. J Hum Genet. 2002. PMID: 12376742
Our results and reports by others indicate that, besides colorectal and endometrial cancer, the late-onset endometrioid type of ovarian cancer can be a feature of families with MSH6 germline mutations....
Our results and reports by others indicate that, besides colorectal and endometrial cancer, the late-onset endometrioid type of ovarian canc …
Clinical characteristics of hereditary ovarian cancer (HOC) in Poland.
Menkiszak J, Górski B, Jakubowska A, Gronwald J, Huzarski T, Byrski T, Foszczyńska-Kłoda M, Fliciński J, Brzosko M, Rzepka-Górska I, Lubiński J. Menkiszak J, et al. Among authors: jakubowska a. Ginekol Pol. 2002 Sep;73(9):733-9. Ginekol Pol. 2002. PMID: 12602271
[Characteristics of selected features of hereditary ovarian cancer in carriers of constitutional BRCA1 gene mutation].
Menkiszak J, Górski B, Jakubowska A, Gronwald J, Huzarski T, Byrski T, Foszczyńska-Kłoda M, Fliciński J, Brzosko M, Rzepka-Górska I, Jan L. Menkiszak J, et al. Among authors: jakubowska a. Ginekol Pol. 2002 Nov;73(11):1084-9. Ginekol Pol. 2002. PMID: 12722403 Polish.
BACKGROUND: Hereditary ovarian cancer in BRCA1 constitutional mutation carriers shows a characteristic clinical pattern. AIM OF THE STUDY: Evaluation of the type of mutation, age of onset, clinical stage (FIGO) and morphological grade (G) of ovarian cancers in BRCA1 mutati …
BACKGROUND: Hereditary ovarian cancer in BRCA1 constitutional mutation carriers shows a characteristic clinical pattern. AIM OF THE S …
Hereditary ovarian cancer in Poland.
Menkiszak J, Gronwald J, Górski B, Jakubowska A, Huzarski T, Byrski T, Foszczyńska-Kłoda M, Haus O, Janiszewska H, Perkowska M, Brozek I, Grzybowska E, Zientek H, Góźdź S, Kozak-Klonowska B, Urbański K, Miturski R, Kowalczyk J, Pluzańska A, Niepsuj S, Koc J, Szwiec M, Drosik K, Mackiewicz A, Lamperska K, Strózyk E, Godlewski D, Stawicka M, Waśko B, Bebenek M, Rozmiarek A, Rzepka-Górska I, Narod SA, Lubiński J. Menkiszak J, et al. Among authors: jakubowska a. Int J Cancer. 2003 Oct 10;106(6):942-5. doi: 10.1002/ijc.11338. Int J Cancer. 2003. PMID: 12918074
There is increasing evidence that hereditary factors play a greater role in ovarian cancer than in any of the other common cancers of adulthood. This is attributable, to a large extent, to a high frequency of mutations in the BRCA1 or BRCA2 genes. In Poland, …
There is increasing evidence that hereditary factors play a greater role in ovarian cancer than in any of the other common cancers of …
A high frequency of BRCA2 gene mutations in Polish families with ovarian and stomach cancer.
Jakubowska A, Scott R, Menkiszak J, Gronwald J, Byrski T, Huzarski T, Górski B, Cybulski C, Debniak T, Kowalska E, Starzyńska T, Ławniczak M, Narod S, Lubinski J. Jakubowska A, et al. Eur J Hum Genet. 2003 Dec;11(12):955-8. doi: 10.1038/sj.ejhg.5201064. Eur J Hum Genet. 2003. PMID: 14647210
In this study, we evaluated the importance of a family history of stomach cancer in predicting the presence of a BRCA2 mutation in Polish patients with ovarian cancer. A BRCA2 mutation was found in eight of 34 women with ovarian cancer and a family his …
In this study, we evaluated the importance of a family history of stomach cancer in predicting the presence of a BRCA2 mutatio …
Clinical features of familial ovarian cancer lacking mutations in BRCA1 or BRCA2.
Menkiszak J, Gronwald J, Górski B, Byrski T, Huzarski T, Jakubowska A, Foszczyńska-Kłoda M, Brzosko M, Fliciński J, Rzepka-Górska I, Narod SA, Lubiński J. Menkiszak J, et al. Among authors: jakubowska a. Eur J Gynaecol Oncol. 2004;25(1):99-100. Eur J Gynaecol Oncol. 2004. PMID: 15053073
PURPOSE OF INVESTIGATION: The purpose of the present study was to identify the clinical and pathologic features of ovarian cancers in patients who have a family history of breast or ovarian cancer but who do not have a mutation in the BRCA1 or BRCA2 gene. ...Ten of …
PURPOSE OF INVESTIGATION: The purpose of the present study was to identify the clinical and pathologic features of ovarian cancers in patien …
Ovarian cystadenoma as a characteristic feature of families with hereditary ovarian cancers unassociated with BRCA1 and BRCA2 mutations.
Menkiszak J, Brzosko M, Górski B, Fliciński J, Jakubowska A, Zebiełowicz D, Gronwald J, Huzarski T, Byrski T, Teresiński L, Chosia M, Rzepka-Górska I, Lubiński J. Menkiszak J, et al. Among authors: jakubowska a. J Appl Genet. 2004;45(2):255-63. J Appl Genet. 2004. PMID: 15131356
The study aimed to determine whether hereditary ovarian cancers that are not caused by BRCA1/BRCA2 constitutional mutations are associated with a predisposition to cystadenoma. ...The second control group comprised 124 female patients for whom the only reason for the exami …
The study aimed to determine whether hereditary ovarian cancers that are not caused by BRCA1/BRCA2 constitutional mutations are associated w …
Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and ovarian cancer risks.
Jakubowska A, Gronwald J, Menkiszak J, Górski B, Huzarski T, Byrski T, Edler L, Lubiński J, Scott RJ, Hamann U. Jakubowska A, et al. Breast Cancer Res Treat. 2007 Sep;104(3):299-308. doi: 10.1007/s10549-006-9417-3. Epub 2006 Oct 25. Breast Cancer Res Treat. 2007. PMID: 17063264
Methylenetetrahydrofolate reductase (MTHFR), a key regulatory enzyme in the metabolism of folate, is suspected to play a role in the etiology of cancer, via its effects on DNA methylation and nucleotide synthesis. ...The MTHFR_1298_A > C polymorphism was o …
Methylenetetrahydrofolate reductase (MTHFR), a key regulatory enzyme in the metabolism of folate, is suspected to play a role …
429 results
Jump to page
Feedback